These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17056815)

  • 21. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection.
    Gorski SA; Hahn YS; Braciale TJ
    PLoS Pathog; 2013 Sep; 9(9):e1003615. PubMed ID: 24068930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection.
    Kim H; Jang M; Kim Y; Choi J; Jeon J; Kim J; Hwang YI; Kang JS; Lee WJ
    J Pharm Pharmacol; 2016 Mar; 68(3):406-20. PubMed ID: 26898166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of Euglena gracilis Z and its carbohydrate storage substance provides survival protection against influenza virus infection in mice.
    Nakashima A; Suzuki K; Asayama Y; Konno M; Saito K; Yamazaki N; Takimoto H
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):379-383. PubMed ID: 28974421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs.
    Dwivedi V; Manickam C; Dhakal S; Binjawadagi B; Ouyang K; Hiremath J; Khatri M; Hague JG; Lee CW; Renukaradhya GJ
    Vet Microbiol; 2016 Apr; 186():157-63. PubMed ID: 27016770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Killing of avian and Swine influenza virus by natural killer cells.
    Achdout H; Meningher T; Hirsh S; Glasner A; Bar-On Y; Gur C; Porgador A; Mendelson M; Mandelboim M; Mandelboim O
    J Virol; 2010 Apr; 84(8):3993-4001. PubMed ID: 20130050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term re-feeding of previously energy-restricted C57BL/6 male mice restores body weight and body fat and attenuates the decline in natural killer cell function after primary influenza infection.
    Clinthorne JF; Adams DJ; Fenton JI; Ritz BW; Gardner EM
    J Nutr; 2010 Aug; 140(8):1495-501. PubMed ID: 20534876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.
    Guo H; Topham DJ
    J Virol; 2010 Aug; 84(15):7750-9. PubMed ID: 20504940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine.
    Williams CM; Roy S; Califano D; McKenzie ANJ; Metzger DW; Furuya Y
    J Virol; 2021 Oct; 95(22):e0059821. PubMed ID: 34468174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of natural killer cell activity by restraint stress during an influenza A/PR8 infection in mice.
    Hunzeker J; Padgett DA; Sheridan PA; Dhabhar FS; Sheridan JF
    Brain Behav Immun; 2004 Nov; 18(6):526-35. PubMed ID: 15331123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
    Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
    Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
    Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The protective effects of intranasal administration of IL-12 given before influenza virus infection and the negative effects of IL-12 treatment given after viral infection.
    Ishikawa H; Ino S; Sasaki H; Fukui T; Kohda C; Tanaka K
    J Med Virol; 2016 Sep; 88(9):1487-96. PubMed ID: 26864280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs.
    Dhakal S; Cheng X; Salcido J; Renu S; Bondra K; Lakshmanappa YS; Misch C; Ghimire S; Feliciano-Ruiz N; Hogshead B; Krakowka S; Carson K; McDonough J; Lee CW; Renukaradhya GJ
    Int J Nanomedicine; 2018; 13():6699-6715. PubMed ID: 30425484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice.
    Izumo T; Maekawa T; Ida M; Noguchi A; Kitagawa Y; Shibata H; Yasui H; Kiso Y
    Int Immunopharmacol; 2010 Sep; 10(9):1101-6. PubMed ID: 20601181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of interleukin-12 in primary influenza virus infection.
    Monteiro JM; Harvey C; Trinchieri G
    J Virol; 1998 Jun; 72(6):4825-31. PubMed ID: 9573248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
    Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
    Front Immunol; 2018; 9():295. PubMed ID: 29515589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in natural killer activity in the influenza virus infection of mice and in treating lymphocytes with the influenza virus and its proteins in vitro].
    Trushinskaia GN; Gubareva LV; Parasiuk NA; Ivanova VT; Zhadanov VM
    Vopr Virusol; 1988; 33(1):11-7. PubMed ID: 3259351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
    Kambayashi T; Assarsson E; Michaëlsson J; Berglund P; Diehl AD; Chambers BJ; Ljunggren HG
    J Immunol; 2000 Nov; 165(9):4964-9. PubMed ID: 11046023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.